Inquiry Basket
Loading ......
Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) has established itself as the most economically significant pathogen affecting swine production worldwide. Known colloquially as the "blue-ear pig disease" due to the cyanotic discoloration sometimes observed in affected animals, PRRSV causes a devastating combination of reproductive failure in breeding stock and severe respiratory disease in growing pigs. Despite decades of intensive research and vaccination efforts, this elusive arterivirus continues to evolve, evade immune responses, and exact a heavy toll on pork producers across the globe. Understanding the complex biology, epidemiology, and clinical impact of PRRSV is essential for anyone involved in modern swine production and veterinary medicine.
Figure 1. Viral Biology and Genome Structure of Porcine Reproductive and Respiratory Syndrome Virus. (Dey S,et al.2024)
PRRSV is a small, spherical virus with a diameter of approximately 50-60 nanometers, featuring an outer lipid envelope derived from the host cell membrane and an inner icosahedral capsid. The viral genome is a single molecule of positive-sense RNA, approximately 15 kilobases in length, with a 5' cap and a 3' polyadenylated tail. These structural elements are critical for viral replication and translation, as the 5' cap facilitates recognition by host ribosomes, while the polyadenylated tail enhances mRNA stability. The PRRSV genome encodes at least 10 open reading frames (ORFs) that are translated into a series of structural and non-structural proteins. The 5' two-thirds of the genome contains ORF1a and ORF1b, which encode two large polyproteins (pp1a and pp1ab). These polyproteins are cleaved by viral proteases into 16 non-structural proteins (nsp1 to nsp16), which are essential for viral replication, transcription, and immune evasion. Key non-structural proteins include nsp1α and nsp1β, which suppress host antiviral responses; nsp2, which is involved in viral replication complex formation; and nsp9, the viral RNA-dependent RNA polymerase (RdRP) responsible for synthesizing new viral genomes.
PRRSV has a global distribution, affecting swine populations in nearly all major pork-producing countries. The virus is highly contagious and can spread rapidly within and between swine herds through multiple pathways. The primary route of transmission is direct contact between infected and susceptible pigs, including through respiratory secretions, saliva, urine, and feces. Infected sows can also transmit the virus to their offspring during pregnancy or through colostrum and milk, leading to congenital infections in piglets. Indirect transmission is also common, occurring through contaminated equipment, feed, water, fomites, and personnel. Insects and rodents may also act as mechanical vectors, facilitating the spread of the virus between herds. PRRSV can persist in the environment for several days under favorable conditions (cool, moist environments) and can remain in infected pigs for weeks to months, serving as a reservoir for ongoing transmission. Additionally, asymptomatic carrier pigs play a critical role in the spread of the virus, as they can shed the virus without showing clinical signs, making detection and control challenging.
PRRSV infection causes two main clinical syndromes: reproductive failure in breeding herds and respiratory disease in growing pigs, though the severity of symptoms varies depending on the virus strain, pig age, and herd immunity. In breeding herds, the most characteristic signs include infertility, abortions (typically in the third trimester of pregnancy), stillbirths, mummified fetuses, and weak piglets that die shortly after birth. Sows may also exhibit mild fever, lethargy, decreased appetite, and reduced milk production, leading to poor piglet survival. In growing pigs (weaners and finishers), PRRSV causes a respiratory syndrome characterized by fever, cough, sneezing, difficulty breathing, lethargy, reduced appetite, and poor growth performance. In severe cases, the virus can lead to secondary bacterial infections (such as Streptococcus suis, Pasteurella multocida, and Haemophilus parasuis), which exacerbate respiratory symptoms and increase mortality. Piglets infected at a young age are particularly susceptible to severe disease, with mortality rates ranging from 10% to 50% in affected herds.
The pathogenesis of PRRSV centers on its tropism for cells of the monocyte-macrophage lineage. Primary replication occurs in alveolar macrophages of the lung, as well as pulmonary intravascular macrophages, subsets of macrophages in lymph nodes and spleen, and intravascular macrophages of the placenta and umbilical cord. The virus gains entry through specific receptors, most notably CD163. Following entry, PRRSV orchestrates a sophisticated assault on the host immune system. Infection of macrophages leads to their destruction, impairing the pig's first line of defense against pathogens. This immunosuppression predisposes affected animals to exacerbation of clinical disease upon coinfection with other agents. Common secondary invaders include Streptococcus suis, Escherichia coli, Salmonella Choleraesuis, Glaesserella parasuis, Pasteurella multocida, Mycoplasma hyopneumoniae, and viruses such as porcine circovirus type 2 and influenza A virus. The resulting polymicrobial disease is often more severe than PRRS alone.
Porcine Reproductive and Respiratory Syndrome Virus remains one of the most complex and costly pathogens confronting global swine production. Its genetic diversity, capacity for immune evasion, and multiple transmission routes create formidable obstacles to control. Yet the intensive research efforts sparked by its emergence three decades ago have yielded deep insights into viral pathogenesis, host immunity, and the epidemiology of livestock diseases. From the development of MLV vaccines to the promise of CD163-edited pigs, progress continues toward the ultimate goal of PRRSV control and elimination. As the virus continues to evolve, so too must the strategies deployed against it—a dynamic challenge requiring ongoing collaboration between researchers, veterinarians, and producers worldwide.
Reference
| Target | Cat. No. | Product Name | Host | Isotype | Application | |
| PRRSV NP | CABT-CS946 | Magic™ Mouse Anti-PRRSV NP Monoclonal antibody, clone 1137 | Mouse | lgG2a | ELISA (Cap), WB, IF, IHC | Inquiry |
| PRRSV NP | CABT-CS947 | Magic™ Mouse Anti-PRRSV NP Monoclonal antibody, clone 1138 | Mouse | lgG2a | ELISA (Det), WB, IF, IHC | Inquiry |
| Target | Cat. No. | Product Name | Host | |
| PRRSV | DAGA-2015 | Recombinant HP-PRRSV Nucleocapsid Protein [His] | E. coli | Inquiry |
| PRRSV | DAGA-2016 | HP-PRRSV nsp7 (aa 2051-2308) [His] | E. coli | Inquiry |
| PRRSV | DAGC754 | Recombinant PRRSV GP5 Protein [His] | Baculovirus | Inquiry |
| PRRSV | DAG-WT806 | Recombinant PRRSV N-NSP7 Fusion Antigen | E. coli | Inquiry |
| PRRSV | DAG-WT1143 | Recombinant PRRSV GP5 Protein [His] | E. coli | Inquiry |
Loading ......
